Crossmark

Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance

Crossref DOI link: https://doi.org/10.1016/j.jacl.2015.12.025

Published Print: 2016-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Thompson, Paul D.

MacDougall, Diane E.

Newton, Roger S.

Margulies, Janice R.

Hanselman, Jeffrey C.

Orloff, David G.

McKenney, James M.

Ballantyne, Christie M.
License Information

Text and Data Mining valid from 2016-05-01

Version of Record valid from 2016-01-05
More Information

This article is maintained by: Elsevier

Article Title: Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance

Journal Title: Journal of Clinical Lipidology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacl.2015.12.025

Content Type: article

Copyright: © 2016 National Lipid Association.

Document is current

Any future updates will be listed below